Abstract
Being a member of the Licensing Committee, providing recommendations to the Danish National Board of Health, which approves marketing authorisation of new medicines, I would prefer to discuss the topic from a Danish viewpoint.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
CIOMS (1990). International Reporting of Adverse Drug Reactions. Final Report of CIOMS Working Group. CIOMS, Geneva.
CIOMS (1992). International Reporting of Periodic Drug Safety Update Summaries. Final Report of CIOMS Working Group II. CIOMS,Geneva.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Schou, J., Papaluca, M. (1994). The acceptability of foreign data in the registration of new medicines. In: Walker, S., Lumley, C., McAuslane, N. (eds) The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines. CMR Workshop Series. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1420-2_13
Download citation
DOI: https://doi.org/10.1007/978-94-011-1420-2_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-4621-3
Online ISBN: 978-94-011-1420-2
eBook Packages: Springer Book Archive